Advertisement

Topics

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

2014-08-27 03:47:38 | BioPortfolio

Summary

RATIONALE: Patients with gliomas may be at risk for developing blood clots. Learning about the risk factors for developing blood clots may help doctors plan better treatment for gliomas.

PURPOSE: This clinical trial is studying risk factors for developing blood clots in patients who are undergoing cancer treatment for newly diagnosed gliomas.

Description

OBJECTIVES:

Primary

- Determine the overall hazard rate of first venous thromboembolism per person-year of follow-up in patients undergoing antineoplastic therapy for newly diagnosed high-grade gliomas.

- Correlate ABO blood type with incidence of venous thromboembolism in these patients.

- Correlate factor VIII level with incidence of venous thromboembolism in these patients.

Secondary

- Determine the overall and individual incidence rate of thromboembolism in these patients.

- Correlate clinical variables, such as type of antineoplastic treatments, Karnofsky performance status, and type of tumor, with incidence of venous thromboembolism in these patients.

- Correlate demographic factors, such as age, with incidence of venous thromboembolism in these patients.

OUTLINE: This is a pilot, multicenter study.

Patients undergo blood collection for blood typing (if not already obtained) and factor VIII and C-reactive protein levels at baseline. Patients are followed to obtain information on their Karnofsky performance status, treatment they receive for their brain tumor, and occurrence of any thrombotic events (e.g., pulmonary embolism or deep-vein thrombosis). Patients are followed every 28 days until the development of thrombotic events, after which they are followed every 2 months for survival.

PROJECTED ACCRUAL: A total of 107 patients will be accrued for this study.

Study Design

N/A

Conditions

Brain and Central Nervous System Tumors

Intervention

laboratory biomarker analysis, physiologic testing, management of therapy complications

Location

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham
Alabama
United States
35294

Status

Completed

Source

National Cancer Institute (NCI)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:47:38-0400

Clinical Trials [3365 Associated Clinical Trials listed on BioPortfolio]

Screening to Predict Weight Loss in Patients With Cancer

RATIONALE: Screening tests may identify people with cancer who are at high risk of losing weight and help doctors plan better treatment. PURPOSE: This clinical trial is studying how well ...

Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

RATIONALE: Measuring levels of interleukin-6 and depression may help doctors understand the relationship between interleukin-6 and depression. It may also help the study of cancer in the f...

Side Effects of Radiation Therapy in Young Patients With CNS Tumors

RATIONALE: Radiation therapy directed at the central nervous system may change the way blood vessels form in young patients. It may also change brain function, the ability to see and hear,...

Clinical Evaluations and Laboratory Studies in Patients With Chronic Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant

RATIONALE: Gathering information about patients with chronic graft-versus-host disease who have undergone a previous donor stem cell transplant may help doctors learn more about the diseas...

Stress and Coping in Caregivers of Younger Patients With Cancer

This research trial studies stress and coping in caregivers of younger patients with cancer. Learning how caregivers of children with cancer experience and cope with chronic stress may hel...

PubMed Articles [34961 Associated PubMed Articles listed on BioPortfolio]

Procalcitonin-guided antibiotic therapy: an expert consensus.

Procalcitonin (PCT) is a useful biomarker of bacterial infection and its use is associated to reduced duration of antibiotic therapy in the setting of intensive care medicine. To address the need of p...

Angioinvasive Fungal Infections Impacting the Skin: Diagnosis, Management, and Complications (Part 2).

As discussed in Part I, angioinvasive fungal infections pose a significant risk to immunocompromised and immunocompetent patients alike, with potential for severe morbidity and high mortality. Part I ...

The role of circulating free DNA in the management of NSCLC.

Circulating cell-free DNA (cfDNA) testing has emerged as an alternative to tumor tissue analyses for the management of metastatic non-small-cell lung cancer (NSCLC) patients. Analysis of cfDNA is a mi...

Guidance for quality control practices and precision goals for CBCs based on IQMH patterns-of-practice survey.

Effective medical laboratory quality management systems ensure confidence in analyzing and reporting accurate and reliable patient results. To guarantee quality assurance, each laboratory needs approp...

Targeted Management of Influenza A/B Outbreaks Incorporating the cobas® Influenza A/B & RSV into the Virology Laboratory.

During the 2017/18 influenza season, our virology laboratory implemented the cobas® Influenza A/B & RSV (Roche Molecular Diagnostics, Pleasanton, CA) for influenza outbreak management in 2 scenarios:...

Medical and Biotech [MESH] Definitions

Laboratory testing and diagnostic imaging services offered to consumers outside of the patient-physician relationship.

Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry.

Assessments aimed at determining agreement in diagnostic test results among laboratories. Identical survey samples are distributed to participating laboratories, with results stratified according to testing methodologies.

The auxiliary health profession which makes use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction of anatomic or physiologic origin.

Analysis of the level of specific BIOMARKERS in a pregnant woman's sera to identify those at risk for PREGNANCY COMPLICATIONS or BIRTH DEFECTS.

More From BioPortfolio on "Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Searches Linking to this Trial